DOCSLIB.ORG

A New Synthetic Route to the Skeleton of Saxitoxin, a Naturally Occurring Blocker of Voltage ─ Gated Sodium Channels Yusuke Sawayama and Toshio Nishikawa ＊

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A New Synthetic Route to the Skeleton of Saxitoxin, a Naturally Occurring Blocker of Voltage ─ Gated Sodium Channels Yusuke Sawayama and Toshio Nishikawa ＊ A New Synthetic Route to the Skeleton of Saxitoxin, a Naturally Occurring Blocker of Voltage ─ Gated Sodium Channels Yusuke Sawayama and Toshio Nishikawa ＊ Department of Applied Biological Sciences, Graduate School of Bioagricultural Sciences, Nagoya University Nagoya 464 ─ 8601, Japan (Received July 2, 2012; E ─ mail: [email protected]) Abstract: Saxitoxin is as potent and specic blocker of voltage ─ gated sodium channels as tetrodotoxin. This unique biological activity has established the importance of these two small natural products in neurophysio- logical experiments. In order to nd new blockers of the voltage ─ gated sodium channels, an efcient synthetic route to the skeleton of saxitoxin was developed. This new synthetic route is based on two key reactions (i) cascade cyclization of a guanidino ─ acetylene initiated by the bromocation (Br ＋) and (ii) transformation of the geminal ─ dibromomethylene moiety to enol acetate, and culminated in the total synthesis of decarbamoyl ─ α ─ saxitoxinol, a naturally ─ occurring analog of saxitoxin. 1． Introduction Saxitoxin (1, STX) and tetrodotoxin (2, TTX) are famous marine natural products isolated as toxic principles of para- lytic shellsh poison (PSP) and puffersh intoxication, respec- tively (Figure 1). 1 These two small natural toxins exert their potent toxicity by specic blockage of sodium ion inux through voltage ─ gated sodium channels (VGSC) without interfering with any other ion channels such as potassium or chloride channels on the neuro cell membrane. 2 Due to this unique biological property and their high afnity for the VGSC, STX and TTX have played signicant roles in the identication and elucidation of the biological function(s) of the channel proteins. 3 Figure 2. (a) The schematic structure of VGSC and (b) the subtypes (isoforms) of human VGSC. Figure 1. Saxitoxin (1, STX) and tetrodotoxin (2, TTX), naturally occurring VGSC blockers. Recently, genetic analyses have revealed that ten subtypes (isoforms) of VGSC (Na v 1.1 ─ 1.9 and Na x) are expressed in different organs of mammals, and that each subtype has differ- ent and unique biological functions (Figure 2). 4 For example, Na v 1.5 is predominantly expressed in cardiac muscle, while Na v 1.7 and 1.8 are found in central neurons and are responsi- ble for the sensation of pain. Interestingly, Na v 1.5, 1.7 and 1.9 are not inhibited by STX and TTX (so ─ called TTX ─ resistant sodium channels). Subtype ─ selective VGSC inhibitors there- fore are highly desired, not only for analyses of channel bio- logical functions, but also for the development of drugs for the treatment of epilepsy, pain and arrhythmia. Several subtype ─ selective inhibitors based on the structures of TTX and STX 5 have been reported (Figure 3); 4,9 ─ anhydro ─ TTX (3), a natu- 6 ral analog of TTX, selectively inhibited Na v 1.6, compound 4, a simplied analog of STX shows inhibitory activity of Na v Figure 3. Subtype ─ selective inhibitors of VGSC. 1 178 （ 70 ） J. Synth. Org. Chem., Jpn. 有機合成化学70-11＿0006論文_Sawayama.indd 70 2012/10/19 14:05:24 7 1.1 and 1.2, and STX ─ related compound 5 inhibits Na v 1.4 ration of diverse STX analogs for developing subtype ─ selective 8 and 1.5. On the other hand, A ─ 803467 (6), a compound struc- blockers of VGSC. turally unrelated to TTX or STX, was also reported to be a Initial Synthetic Strategy potent and selective blocker of Na v 1.8, and has been devel- Our initial idea for the synthesis of STX arose with recog- oped as a therapeutic agent for neuropathic and inammatory nition of the single carbon chain in the STX core skeleton, pain. We have also been interested in developing subtype ─ which inspired us to conceive a new synthetic route commenc- selective inhibitors of VGSC based on STX and TTX. 9 This ing from a simple intermediate B as shown in Scheme 1. We account describes the details of our synthetic efforts toward envisioned that the tricyclic skeleton of STX would be con- STX, focusing on synthesis of the guanidine ─ containing core structed from a bis ─ guanidino ─ acetylene A by double halocy- structure as well as the underlying logic and strategy. 10 clizations (A to C & C to D) for the synthesis of the two cyclic guanidines, and an intramolecular N ─ alkylation for the pyrro- 2． Synthetic Strategy Toward the STX Skeleton lidine synthesis (D to E). We expected these three cyclizations Saxitoxin (1) is a representative densely ─ functionalized would proceed in cascade fashion, or in one ─ pot. The precur- natural product. The molecular formula (C 10H 19N 7O 4), and the sor A for this cascade cyclization could be readily prepared by structure containing two cyclic guanidiniums and a hydrated bis ─ guanylation of an anti ─ diaminoacetylene B, a relatively ketone clearly indicate the special features that characterize a simple compound. 18 heteroatom ─ rich small molecule. Since more than thirty ana- This strategy relies on two reactions; (i) cascade bromocy- logs of STX have been isolated from nature, a synthetic route clizations (halocyclizations) of a guanidino ─ acetylene, and (ii) to STX should enable access to these various analogs, includ- transformation of the geminal ─ dibromomethylene moiety to a ing neosaxitoxin (7, N ─ hydroxylated), gonyautoxin 3 (8, sulfo- ketone (E to STX skeleton). When we initiated this project, a nated) and zetekitoxin AB (9) shown in Figure 4. 11 few examples of the former transformation had been reported. 19 ─ 21 and the latter transformation had been reported only for specic substrates (vide infra). First of all however, we prepared a possible precursor 10, and attempted the cascade reaction by exposing it to sources of the bromocation (Br ＋) such as NBS and pyridinium tribromide (PyHBr 3) (Scheme 2). However, to our disappointment, the desired bicyclic guanidine 12 was not obtained at all. Instead, ve ─ membered guanidine 11 was obtained in a poor yield under a limited range of condi- tions, while six ─ membered cyclic guanidine product was not detected. When the product 11 was isolated and exposed to Br ＋ again, the second cyclization did not proceed. These results Figure 4. Naturally ─ occurring Analogs of STX. led us to suppose that the rate of ve ─ membered cyclization was much faster than that of six, and that the ve ─ membered Due to its unique structure as well as its potent biological ring product might not be a suitable precursor for the second activity, STX has been an attractive synthetic target for natural cyclization. However, we had not yet understood the whole product synthesis since its structure elucidation in 1970s. 12 To picture concerning the bromocyclization of guanidino ─ acety- date ve researchers Kishi, 13 Jacobi, 14 Du Bois, 15 Nagasawa 16 lenes. We therefore decided at this stage to investigate optimi- and Looper 17 have independently reported elegant total syn- zation of the conditions and the regioselectivites for the bro- theses of STX and its analogs. Although their synthetic routes mocyclization of guanidino ─ acetylenes by utilizing model are all unique and efcient, a simpler, more versatile synthetic compounds. route has been desired to make possible the expeditious prepa- In the halocyclization of a guanidino ─ acetylene, there are Scheme 1. Our initial synthetic strategy for construction of the STX skeleton. Vol.70 No.11 2012 （ 71 ） 1179 有機合成化学70-11＿0006論文_Sawayama.indd 71 2012/10/19 14:05:28 Scheme 2. The rst attempt at a cascade bromocyclization of Scheme 3. Two possible modes of bromocyclization for (a) propar- bis ─ guanidino ─ acetylene 10. gyl guanidine F and (b) homopropargyl guanidine I for the synthesis of the STX skeleton. two possible modes of cyclization; the exo ─ and endo ─ modes (Scheme 3). Propargyl guanidine F can undergo 5 ─ exo ─ dig cyclization and/or 6 ─ endo ─ dig cyclization, leading to ve ─ membered ring product G and/or six ─ membered ring product ＋ H, respectively (Scheme 3(a)). On the other hand, homo- the source of bromocation (Br ), no reaction was observed, propargyl guanidine I can undergo 5 ─ endo ─ dig cyclization indicating the poor reactivity of this reagent. We next exam- ＋ and/or 6 ─ exo ─ dig cyclization leading to ve ─ membered ring ined pyridinium tribromide (PyHBr 3) as a more reactive Br product J and/or six ─ membered ring product K (Scheme 3(b)). source (Table 1). When 13a was treated with PyHBr 3 in the Although both 6 ─ endo ─ dig and 5 ─ endo ─ dig cyclizations may presence of K 2CO 3 in CH 2Cl 2, simple bromination of the be possible according to the Baldwin’s rules, 22 we anticipated alkyne moiety took place to give dibromoalkene 15 in a good that the exo ─ mode of cyclization would proceed preferentially yield (entry 1). The same reaction when conducted in a bipha- in both cases to yield the desired cyclic guanidine products G sic solvent system comprising of CH 2Cl 2 and H 2O (1:1) and K, respectively. afforded the spiro ─ hemiaminal 16a as a single diastereomeric product in moderate yield (entry 2). This result indicates that 3． Bromocyclization of Guanidino ─ acetylenes the expected six ─ membered ring product 14 further reacted ＋ 3.1 Bromocyclization of Homopropargyl Guanidines with an excess amount of Br to give the compound 16a by Bromocyclization of homopropargylguanidine to give the trapping of an iminium ion intermediate by an internal six ─ membered cyclic guanidine was examined rst. Com- hydroxy group. The similar spiro ─ product 16b was obtained in pounds 13a ─ c were selected as model substrates having the better yield, when mono ─ protected guanidine 13b was treated same carbon number as the STX skeleton, and exposed to a under the same conditions (entry 3). In order to intercept and variety of conditions for bromination. Our preliminary experi- isolate the six ─ membered ring product 14, substrate 13c with ments revealed that bromocyclization was better than iodocy- the hydroxy group protected with TBS was exposed to the clization because of product stability.
Load more

Recommended publications
  • Saxitoxin Poisoning (Paralytic Shellfish Poisoning [PSP])
    Saxitoxin Poisoning (Paralytic Shellfish Poisoning [PSP]) PROTOCOL CHECKLIST Enter available information into Merlin upon receipt of initial report Review information on Saxitoxin and its epidemiology, case definition and exposure information Contact provider Interview patient(s) Review facts on Saxitoxin Sources of poisoning Symptoms Clinical information Ask about exposure to relevant risk factors Type of fish or shellfish Size and weight of shellfish/puffer fish or other type of fish Amount of shellfish/puffer fish or other type of fish consumed Where the shellfish/puffer fish or other type of fish was caught or purchased Where the shellfish/puffer fish or other type of fish was consumed Secure any leftover product for potential testing Restaurant meals Other Contact your Regional Environmental Epidemiologist (REE) Identify symptomatic contacts or others who ate the shellfish/puffer fish or other type of fish Enter any additional information gathered into Merlin Saxitoxin Poisoning Guide to Surveillance and Investigation Saxitoxin Poisoning 1. DISEASE REPORTING A. Purpose of reporting and surveillance 1. To gather epidemiologic and environmental data on saxitoxin shellfish, Florida puffer fish or other type of fish poisoning cases to target future public health interventions. 2. To prevent additional cases by identifying any ongoing public health threats that can be mitigated by identifying any shellfish or puffer fish available commercially and removing it from the marketplace or issuing public notices about the risks from consuming molluscan shellfish from Florida and non-Florida waters, such as from the northern Pacific and other cold water sources. 3. To identify all exposed persons with a common or shared exposure to saxitoxic shellfish or puffer fish; collect shellfish and/or puffer fish samples for testing by the Florida Fish and Wildlife Conservation Commission (FWC) and the U.S.
    [Show full text]
  • Microcystis Sp. Co-Producing Microcystin and Saxitoxin from Songkhla Lake Basin, Thailand
    toxins Article Microcystis Sp. Co-Producing Microcystin and Saxitoxin from Songkhla Lake Basin, Thailand Ampapan Naknaen 1, Waraporn Ratsameepakai 2, Oramas Suttinun 1,3, Yaowapa Sukpondma 4, Eakalak Khan 5 and Rattanaruji Pomwised 6,* 1 Environmental Assessment and Technology for Hazardous Waste Management Research Center, Faculty of Environmental Management, Prince of Songkla University, Hat Yai 90110, Thailand; [email protected] (A.N.); [email protected] (O.S.) 2 Office of Scientific Instrument and Testing, Prince of Songkla University, Hat Yai 90110, Thailand; [email protected] 3 Center of Excellence on Hazardous Substance Management (HSM), Bangkok 10330, Thailand 4 Division of Physical Science, Faculty of Science, Prince of Songkla University, Hat Yai 90110, Thailand; [email protected] 5 Department of Civil and Environmental Engineering and Construction, University of Nevada, Las Vegas, NV 89154-4015, USA; [email protected] 6 Division of Biological Science, Faculty of Science, Prince of Songkla University, Hat Yai 90110, Thailand * Correspondence: [email protected]; Tel.: +66-74-288-325 Abstract: The Songkhla Lake Basin (SLB) located in Southern Thailand, has been increasingly polluted by urban and industrial wastewater, while the lake water has been intensively used. Here, we aimed to investigate cyanobacteria and cyanotoxins in the SLB. Ten cyanobacteria isolates were identified as Microcystis genus based on16S rDNA analysis. All isolates harbored microcystin genes, while five of them carried saxitoxin genes. On day 15 of culturing, the specific growth rate and Chl-a content were 0.2–0.3 per day and 4 µg/mL. The total extracellular polymeric substances (EPS) content was Citation: Naknaen, A.; 0.37–0.49 µg/mL.
    [Show full text]
  • Zetekitoxin AB
    Zetekitoxin AB Kate Wilkin Laura Graham Background of Zetekitoxin AB Potent water-soluble guanidinium toxin extracted from the skin of the Panamanian golden frog, Atelopus zeteki. Identified by Harry S. Mosher and colleagues at Stanford University, 1969. Originally named 1,2- atelopidtoxin. Progression 1975 – found chiriquitoxin in a Costa Rican Atelopus frog. 1977 – Mosher isolated 2 components of 1,2-atelopidtoxin. AB major component, more toxic C minor component, less toxic 1986 – purified from skin extracts by Daly and Kim. 1990 – the major component was renamed after the frog species zeteki. Classification Structural Identification Structural Identification - IR -1 Cm Functional Groups 1268 OSO3H 1700 Carbamate 1051 – 1022 C – N Structural Identification – MS Structural Identification – 13C Carbon Number Ppm Assignment 2 ~ 159 C = NH 4 ~ 85 Quaternary Carbon 5 ~ 59 Tertiary Carbon 6 ~ 54 Tertiary Carbon 8 ~ 158 C = NH Structural Identification – 13C Carbon Number Ppm Assignment 10 55 / 43 C H2 - more subst. on ZTX 11 89 / 33 Ring and OSO3H on ZTX 12 ~ 98 Carbon attached to 2 OH groups 19 / 13 70 / 64 ZTX: C – N STX: C – C 20 / 14 ~ 157 Carbamate Structural Identification – 13C Carbon Number Ppm Assignment 13 156 Amide 14 34 CH2 15 54 C – N 16 47 Tertiary Carbon 17 69 C – O – N 18 62 C – OH Structural Identification - 1H Synthesis Synthesis O. Iwamoto and Dr. K. Nagasawa Tokyo University of Agriculture and Technology. October 10th, 2007 “Further work to synthesize natural STXs and various derivatives is in progress with the aim of developing isoform-selective sodium-channel inhibitors” Therapeutic Applications Possible anesthetic, but has poor therapeutic index.
    [Show full text]
  • Biological Toxins Fact Sheet
    Work with FACT SHEET Biological Toxins The University of Utah Institutional Biosafety Committee (IBC) reviews registrations for work with, possession of, use of, and transfer of acute biological toxins (mammalian LD50 <100 µg/kg body weight) or toxins that fall under the Federal Select Agent Guidelines, as well as the organisms, both natural and recombinant, which produce these toxins Toxins Requiring IBC Registration Laboratory Practices Guidelines for working with biological toxins can be found The following toxins require registration with the IBC. The list in Appendix I of the Biosafety in Microbiological and is not comprehensive. Any toxin with an LD50 greater than 100 µg/kg body weight, or on the select agent list requires Biomedical Laboratories registration. Principal investigators should confirm whether or (http://www.cdc.gov/biosafety/publications/bmbl5/i not the toxins they propose to work with require IBC ndex.htm). These are summarized below. registration by contacting the OEHS Biosafety Officer at [email protected] or 801-581-6590. Routine operations with dilute toxin solutions are Abrin conducted using Biosafety Level 2 (BSL2) practices and Aflatoxin these must be detailed in the IBC protocol and will be Bacillus anthracis edema factor verified during the inspection by OEHS staff prior to IBC Bacillus anthracis lethal toxin Botulinum neurotoxins approval. BSL2 Inspection checklists can be found here Brevetoxin (http://oehs.utah.edu/research-safety/biosafety/ Cholera toxin biosafety-laboratory-audits). All personnel working with Clostridium difficile toxin biological toxins or accessing a toxin laboratory must be Clostridium perfringens toxins Conotoxins trained in the theory and practice of the toxins to be used, Dendrotoxin (DTX) with special emphasis on the nature of the hazards Diacetoxyscirpenol (DAS) associated with laboratory operations and should be Diphtheria toxin familiar with the signs and symptoms of toxin exposure.
    [Show full text]
  • Animal Venom Derived Toxins Are Novel Analgesics for Treatment Of
    Short Communication iMedPub Journals 2018 www.imedpub.com Journal of Molecular Sciences Vol.2 No.1:6 Animal Venom Derived Toxins are Novel Upadhyay RK* Analgesics for Treatment of Arthritis Department of Zoology, DDU Gorakhpur University, Gorakhpur, UP, India Abstract *Corresponding authors: Ravi Kant Upadhyay Present review article explains use of animal venom derived toxins as analgesics of the treatment of chronic pain and inflammation occurs in arthritis. It is a [email protected] progressive degenerative joint disease that put major impact on joint function and quality of life. Patients face prolonged inappropriate inflammatory responses and bone erosion. Longer persistent chronic pain is a complex and debilitating Department of Zoology, DDU Gorakhpur condition associated with a large personal, mental, physical and socioeconomic University, Gorakhpur, UttarPradesh, India. burden. However, for mitigation of inflammation and sever pain in joints synthetic analgesics are used to provide quick relief from pain but they impose many long Tel: 9838448495 term side effects. Venom toxins showed high affinity to voltage gated channels, and pain receptors. These are strong inhibitors of ion channels which enable them as potential therapeutic agents for the treatment of pain. Present article Citation: Upadhyay RK (2018) Animal Venom emphasizes development of a new class of analgesic agents in form of venom Derived Toxins are Novel Analgesics for derived toxins for the treatment of arthritis. Treatment of Arthritis. J Mol Sci. Vol.2 No.1:6 Keywords: Analgesics; Venom toxins; Ion channels; Channel inhibitors; Pain; Inflammation Received: February 04, 2018; Accepted: March 12, 2018; Published: March 19, 2018 Introduction such as the back, spine, and pelvis.
    [Show full text]
  • Cyanobacterial Toxins: Saxitoxins
    WHO/SDE/WSH/xxxxx English only Cyanobacterial toxins: Saxitoxins Background document for development of WHO Guidelines for Drinking-water Quality and Guidelines for Safe Recreational Water Environments Version for Public Review Nov 2019 © World Health Organization 20XX Preface Information on cyanobacterial toxins, including saxitoxins, is comprehensively reviewed in a recent volume to be published by the World Health Organization, “Toxic Cyanobacteria in Water” (TCiW; Chorus & Welker, in press). This covers chemical properties of the toxins and information on the cyanobacteria producing them as well as guidance on assessing the risks of their occurrence, monitoring and management. In contrast, this background document focuses on reviewing the toxicological information available for guideline value derivation and the considerations for deriving the guideline values for saxitoxin in water. Sections 1-3 and 8 are largely summaries of respective chapters in TCiW and references to original studies can be found therein. To be written by WHO Secretariat Acknowledgements To be written by WHO Secretariat 5 Abbreviations used in text ARfD Acute Reference Dose bw body weight C Volume of drinking water assumed to be consumed daily by an adult GTX Gonyautoxin i.p. intraperitoneal i.v. intravenous LOAEL Lowest Observed Adverse Effect Level neoSTX Neosaxitoxin NOAEL No Observed Adverse Effect Level P Proportion of exposure assumed to be due to drinking water PSP Paralytic Shellfish Poisoning PST paralytic shellfish toxin STX saxitoxin STXOL saxitoxinol
    [Show full text]
  • Saxitoxin and ,U-Conotoxins (Brain/Electric Organ/Heart/Tetrodotoxin) EDWARD MOCZYDLOWSKI*, BALDOMERO M
    Proc. Nati. Acad. Sci. USA Vol. 83, pp. 5321-5325, July 1986 Neurobiology Discrimination of muscle and neuronal Na-channel subtypes by binding competition between [3H]saxitoxin and ,u-conotoxins (brain/electric organ/heart/tetrodotoxin) EDWARD MOCZYDLOWSKI*, BALDOMERO M. OLIVERAt, WILLIAM R. GRAYt, AND GARY R. STRICHARTZt *Department of Physiology and Biophysics, University of Cincinnati College of Medicine, 231 Bethesda Avenue, Cincinnati, OH 45267-0576; tDepartment of Biology, University of Utah, Salt Lake City, UT 84112; and tAnesthesia Research Laboratories and the Department of Pharmacology, Harvard Medical School, Boston, MA 02115 Communicated by Norman Davidson, March 17, 1986 ABSTRACT The effect oftwo pL-conotoxin peptides on the 22 amino acids with amidated carboxyl termini (18). One of specific binding of [3H]saxitoxin was examined in isolated these toxins, GIIIA, has recently been shown to block muscle plasma membranes of various excitable tissues. pt-Conotoxins action potentials (18) and macroscopic Na current in a GITIA and GIHIB inhibit [3H]saxitoxin binding inlEkctrophorus voltage-clamped frog muscle fiber (19). At the single channel electric organ membranes with similar Kds of %50 x 10-9 M level, the kinetics of GIIIA block have been shown to in a manner consistent with direct competition for a common conform to a single-site binding model (Kd, 110 x 10-9 M at binding site. GITIA and GIIIB similarly compete with the 0 mV), from analysis of the statistics of discrete blocking majority (80-95%) of [3Hlsaxitoxin binding sites in rat skeletal events induced in batrachotoxin-activated Na channels from muscle with Kds of -25 and "140 x 10-9 M, respectively.
    [Show full text]
  • Venom Week 2012 4Th International Scientific Symposium on All Things Venomous
    17th World Congress of the International Society on Toxinology Animal, Plant and Microbial Toxins & Venom Week 2012 4th International Scientific Symposium on All Things Venomous Honolulu, Hawaii, USA, July 8 – 13, 2012 1 Table of Contents Section Page Introduction 01 Scientific Organizing Committee 02 Local Organizing Committee / Sponsors / Co-Chairs 02 Welcome Messages 04 Governor’s Proclamation 08 Meeting Program 10 Sunday 13 Monday 15 Tuesday 20 Wednesday 26 Thursday 30 Friday 36 Poster Session I 41 Poster Session II 47 Supplemental program material 54 Additional Abstracts (#298 – #344) 61 International Society on Thrombosis & Haemostasis 99 2 Introduction Welcome to the 17th World Congress of the International Society on Toxinology (IST), held jointly with Venom Week 2012, 4th International Scientific Symposium on All Things Venomous, in Honolulu, Hawaii, USA, July 8 – 13, 2012. This is a supplement to the special issue of Toxicon. It contains the abstracts that were submitted too late for inclusion there, as well as a complete program agenda of the meeting, as well as other materials. At the time of this printing, we had 344 scientific abstracts scheduled for presentation and over 300 attendees from all over the planet. The World Congress of IST is held every three years, most recently in Recife, Brazil in March 2009. The IST World Congress is the primary international meeting bringing together scientists and physicians from around the world to discuss the most recent advances in the structure and function of natural toxins occurring in venomous animals, plants, or microorganisms, in medical, public health, and policy approaches to prevent or treat envenomations, and in the development of new toxin-derived drugs.
    [Show full text]
  • Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases
    Mar. Drugs 2014, 12, 2539-2589; doi:10.3390/md12052539 OPEN ACCESS marine drugs ISSN 1660–3397 www.mdpi.com/journal/marinedrugs Review Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases Clara Grosso 1, Patrícia Valentão 1, Federico Ferreres 2 and Paula B. Andrade 1,* 1 REQUIMTE/Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, no. 228, 4050-313 Porto, Portugal; E-Mails: [email protected] (C.G.); [email protected] (P.V.) 2 Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS (CSIC), P.O. Box 164, Campus University Espinardo, Murcia 30100, Spain; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +351-22042-8654; Fax: +351-22609-3390. Received: 30 January 2014; in revised form: 10 April 2014 / Accepted: 16 April 2014 / Published: 2 May 2014 Abstract: Marine invertebrates produce a plethora of bioactive compounds, which serve as inspiration for marine biotechnology, particularly in drug discovery programs and biomaterials development. This review aims to summarize the potential of drugs derived from marine invertebrates in the field of neuroscience. Therefore, some examples of neuroprotective drugs and neurotoxins will be discussed. Their role in neuroscience research and development of new therapies targeting the central nervous system will be addressed, with particular focus on neuroinflammation and neurodegeneration. In addition, the neuronal growth promoted by marine drugs, as well as the recent advances in neural tissue engineering, will be highlighted. Keywords: aragonite; conotoxins; neurodegeneration; neuroinflammation; Aβ peptide; tau hyperphosphorylation; protein kinases; receptors; voltage-dependent ion channels; cyclooxygenases Mar.
    [Show full text]
  • Evidence That Tetrodotoxin and Saxitoxin Act at a Metal Cation Binding Site in the Sodium Channels of Nerve Membrane (Solubilized Membrane/Receptors/Surface Charge) R
    Proc. Nat. Acad. Sci. USA 71 Vol. 71, No. 10, pp. 3936-3940, October 1974 Evidence That Tetrodotoxin and Saxitoxin Act at a Metal Cation Binding Site in the Sodium Channels of Nerve Membrane (solubilized membrane/receptors/surface charge) R. HENDERSON*, J. M. RITCHIE, AND G. R. STRICHARTZt Departments of Molecular Biophysics and Biochemistry, and of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510 Communicated by Frederic M. Richards, June 17, 1974 ABSTRACT The effects of monovalent, divalent, and STX. These experiments suggest how the toxins exert their trivalent cations on the binding of tetrodotoxin and saxi- toxin to intact nerves and to a preparation of solubilized action, and provide a unifying explanation of how several nerve membranes have been examined. All eight divalent cations affect nerve membrane permeability. and trivalent cations tested, and the monovalent ions MATERIALS AND LiW, Tl+, and H+ appear to compete reversibly with the METHODS toxins for their binding site. The ability of lithium to Tritium-labeled TTX and STX were prepared and purified reduce toxin binding is paralleled by its ability to reduce (3, 5). Olfactory nerves from garfish, obtained from the Gulf tetrodotoxin-sensitive ion fluxes through the nerve mem- brane. We conclude that the toxins act at a metal cation Specimen Co., Florida, were dissected by the method of binding site in the sodium channel and suggest that this Easton (12). A detergent-solubilized extract of the nerves site is the principal coordination site for cations (normally was prepared by the method of Henderson and Wang (4). Na+ ions) as they pass through the membrane during an Binding experiments were also carried out on intact garfish action potential.
    [Show full text]
  • University of Florida Thesis Or Dissertation Formatting
    PARALYTIC SHELLFISH TOXINS CHARACTERIZED FROM LYNGBYA WOLLEI DOMINATED MATS COLLECTED FROM TWO FLORIDA SPRINGS By AMANDA FOSS A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA 2011 1 © 2011 AMANDA FOSS 2 To my wonderful parents 3 ACKNOWLEDGMENTS I appreciate the support provided me by GreenWater Laboratories, Mark Aubel for his wonderful direction and aid with toxin analysis and Andrew Chapman for his expertise in phycology and sampling. I thank the chair, Ed Phlips, and members of my committee, Nancy Szabo and Karl Havens, for their priceless advice and keen research assistance. I thank Mete Yilmaz for his work on the molecular portion of this study, as well as expertise. I thank Andrew Reich with the Florida Department of Health for collaboration with GreenWater Labs and the research that kick started this project, and, of course a big thank you to Alicia Plakotaris and Johnny May for their help in the field. 4 TABLE OF CONTENTS page ACKNOWLEDGMENTS .................................................................................................. 4 LIST OF TABLES ............................................................................................................ 7 LIST OF FIGURES .......................................................................................................... 8 ABSTRACT ..................................................................................................................
    [Show full text]
  • Herg) Potassium Channel
    Molecular Pharmacology Fast Forward. Published on May 1, 2007 as DOI: 10.1124/mol.107.035840 Molecular PharmacologyThis article has notFast been Forward. copyedited andPublished formatted. The on final May version 1, 2007 may differas doi:10.1124/mol.107.035840 from this version. MOL #35840 1 APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human ether-a-go-go-related (hERG) potassium channel Downloaded from Zhang M, Liu X-S, Diochot S, Lazdunski M, and Tseng G-N 1. Department of Physiology Medical College of Virginia Virginia Commonwealth University molpharm.aspetjournals.org Richmond, VA 23298 (ZM, LXS, TGN) 2. Institut de Pharmacologie Moleculaire et Cellulaire , CNRS UMR 6097, 660 Route des Lucioles, Sophia Antipolis, at ASPET Journals on September 30, 2021 06560 Valbonne, France (DS, LM) Copyright 2007 by the American Society for Pharmacology and Experimental Therapeutics. Molecular Pharmacology Fast Forward. Published on May 1, 2007 as DOI: 10.1124/mol.107.035840 This article has not been copyedited and formatted. The final version may differ from this version. MOL #35840 2 Running head: APETx1 binds to hERG's S3b For correspondence: Gea-Ny Tseng, PhD Department of Physiology Medical College of Virginia Virginia Commonwealth University 1101 E. Marshall Street Richmond, VA 23298 Phone: 804-827-0811 FAX: 804-828-7382 Downloaded from e-mail: [email protected] # of text pages: # of tables: 0 # of figures: 8 molpharm.aspetjournals.org # of references: 54 # of words in Abstract: 198 # of words in Introduction: 607 # of words in Discussion: 1623 Nonstandard abbreviations: hERG = human ether-a-go-go related gene at ASPET Journals on September 30, 2021 Cys = cysteine V0.5 = half-maximum activation voltage zg = equivalent gating charge IC = control current ITx = current in the presence of toxin S3b = carboxyl half of S3 segment Molecular Pharmacology Fast Forward.
    [Show full text]